Tranzactioneaza Adc Therapeutics (US.ADCT) - 2.76 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 2.7800 USD
Ask 2.8600 USD
Minim 2.7600 USD
Maxim 2.7600 USD
Pret referinta 2.7400
Volum -
Volum ultima zi 1
Max 52 sapt 6.0400 USD
Min 52 sapt 0.3800 USD

Descriere companie

ADC Therapeutics SA (https://adctherapeutics.com/) is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Informatii companie

Nume

ADC THERAPEUTICS SA